PMID- 28539110
OWN - NLM
STAT- MEDLINE
DCOM- 20170901
LR  - 20181113
IS  - 1756-994X (Electronic)
IS  - 1756-994X (Linking)
VI  - 9
IP  - 1
DP  - 2017 May 24
TI  - Novel insights into the HLA class I immunopeptidome and T-cell 
      immunosurveillance.
PG  - 44
LID - 10.1186/s13073-017-0439-8 [doi]
LID - 44
AB  - Advances in mass spectrometry have allowed the high-throughput quantitative 
      identification of human leukocyte antigen (HLA) class I ligands, and recent 
      studies have reported on the breadth and diversity of the HLA class I 
      immunopeptidome. These findings have far-reaching implications for 
      immunosurveillance by T cells and translational value for immunotherapy.
FAU - Melief, Cornelis J M
AU  - Melief CJM
AD  - ISA Pharmaceuticals, J.H. Oortweg 19, 2333 CH, Leiden, The Netherlands. 
      melief@isa-pharma.com.
FAU - Kessler, Jan H
AU  - Kessler JH
AD  - ISA Pharmaceuticals, J.H. Oortweg 19, 2333 CH, Leiden, The Netherlands.
LA  - eng
PT  - Editorial
PT  - Review
DEP - 20170524
PL  - England
TA  - Genome Med
JT  - Genome medicine
JID - 101475844
RN  - 0 (Histocompatibility Antigens Class I)
SB  - IM
MH  - *Histocompatibility Antigens Class I
MH  - Humans
MH  - *Immunologic Surveillance
MH  - Immunotherapy
MH  - T-Lymphocytes/immunology/*metabolism
PMC - PMC5442872
EDAT- 2017/05/26 06:00
MHDA- 2017/09/02 06:00
PMCR- 2017/05/24
CRDT- 2017/05/26 06:00
PHST- 2017/05/26 06:00 [entrez]
PHST- 2017/05/26 06:00 [pubmed]
PHST- 2017/09/02 06:00 [medline]
PHST- 2017/05/24 00:00 [pmc-release]
AID - 10.1186/s13073-017-0439-8 [pii]
AID - 439 [pii]
AID - 10.1186/s13073-017-0439-8 [doi]
PST - epublish
SO  - Genome Med. 2017 May 24;9(1):44. doi: 10.1186/s13073-017-0439-8.